Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix

cic.isFulltexttruees
cic.isPeerReviewedtruees
cic.lugarDesarrolloUniversidad Nacional de La Plata es
cic.versioninfo:eu-repo/semantics/submittedVersiones
dc.date.accessioned2016-12-02T17:24:00Z
dc.date.available2016-12-02T17:24:00Z
dc.identifier.urihttps://digital.cic.gba.gob.ar/handle/11746/4897
dc.titleAdvanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrixen
dc.typeArtículoes
dcterms.abstractThe adhesion of osteoblasts to bone extracellular matrix, of which type-I collagen constitutes >85%, can modulate diverse aspects of their physiology such as growth, differentiation and mineralisation. In this study we examined the adhesion of UMR106 rat osteoblast-like cells either to a control (Col) or advanced-glycation-endproduct-modified (AGEs-Col) type I collagen matrix. We investigated the possible role of different integrin receptors in osteoblastic adhesion, by co-incubating these cells either with β-peptide (conserved sequence 113–125 of the β subunit of integrins) or with two other peptides, RGD (Arg-Gly-Asp) and DGEA (Asp-Gly-Glu-Ala), which are recognition sequences for the α-subunits of α1,5β1and α2β1integrins. Collagen glycation inhibited the adhesion of UMR106 osteoblasts to the matrix (40% reduction versus Col,<em>P</em><0.001). β-Peptide showed a dose- and glycation-dependent inhibitory effect on adhesion, and at a concentration of 100μM decreased the attachment of UMR106 cells to both matrices (42% to Col,<em>P</em><0.001; and 25% to AGEs-Col,<em>P</em><0.01). The synthetic peptides RGD (1mM) and DGEA (5mM) inhibited the attachment of UMR106 cells to Col (30 and 20%,<em>P</em><0.01 and<em>P</em><0.001, respectively), but not to AGEs-Col. β-Peptide induced an increase in UMR106 cell clumping and a decrease in cellular spreading, while DGEA increased spreading with cellular extensions in multiple directions. These results indicate that both α and β integrin subunits participate in osteoblastic attachment to type-I collagen, probably through the α1,5β1and α2β1integrins. AGEs-modification of type-I collagen impairs the integrin-mediated adhesion of osteoblastic cells to the matrix, and could thus contribute to the pathogenesis of diabetic osteopenia.en
dcterms.creator.authorMcCarthy, Antonio Desmondes
dcterms.creator.authorUemurab, Toshimasaes
dcterms.creator.authorEtcheverry, Susana B.es
dcterms.creator.authorCortizo, Ana Maríaes
dcterms.extent9 p.es
dcterms.isPartOf.issuevol. 36, no. 5es
dcterms.isPartOf.seriesInternational Journal of Biochemistry and Cell Biologyes
dcterms.issued2004
dcterms.languageIngléses
dcterms.licenseAttribution 4.0 International (BY 4.0)es
dcterms.subjectAdvanced glycation endproductsen
dcterms.subjectOsteoblasten
dcterms.subjectAdhesionen
dcterms.subjectIntegrin receptorsen
dcterms.subjectType-I collagenen
dcterms.subject.materiaCiencias Químicases

Archivos

Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
108 - McCarthy AD-Int J Biochem Cell Biol2004 ARTICULO.pdf-PDFA.pdf
Tamaño:
397.83 KB
Formato:
Adobe Portable Document Format
Descripción:
Documento completo